These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 865381)

  • 1. [Immunogenicity, efficacy and reactogenicity of a human diploid cell strain (HDCS) rabies vaccine in man; recommendations for pre- and post-exposure application (vaccination scheme) (author's transl)].
    Kuwert EK; Marcus I; Höher PG; Werner J; Iwand A; Helm EB
    Med Klin; 1977 May; 72(18):797-805. PubMed ID: 865381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some experiences with human diploid cell strain-(HDCS) rabies vaccine in pre- and post-exposure vaccinated humans.
    Kuwert EK; Marcus I; Werner J; Iwand A; Thraenhart O
    Dev Biol Stand; 1978; 40():79-88. PubMed ID: 680404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-exposure use of human diploid cell culture rabies vaccine.
    Kuwert EK; Marcus I; Werner J; Scheiermann N; Höher PG; Thraenhart O; Hierholzer E; Wiktor TJ; Koprowski H
    Dev Biol Stand; 1976 Dec 13-15; 37():273-86. PubMed ID: 1031689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population.
    Sehgal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year longitudinal study of efficacy and safety of purified Vero cell rabies vaccine for post-exposure prophylaxis of rabies in Indian population.
    Seghal S; Bhattacharya D; Bhardwaj M
    J Commun Dis; 1997 Mar; 29(1):23-8. PubMed ID: 9282525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis.
    Wang LY; Sun MP; Zhang XC; Suo LD; Xu RH; Zou YJ; Zuo LB; Qi H
    Vaccine; 2011 Mar; 29(15):2679-81. PubMed ID: 21296694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the inactivated tissue culture rabies vaccine from the Vnukovo-32 strain. Results of its industrial production and field use for post-exposure immunization of man.
    Selimov M; Aksenova T; Klyueva E; Gribencha L; Lebedeva I
    Dev Biol Stand; 1978; 40():57-62. PubMed ID: 680402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified chick embryo cell (PCEC) rabies vaccine for human use: clinical trials.
    Bijok U; Vodopija I; Smerdel S; Thongcharoen P; Nicholson K; Dietrich M; Gonzalez de Cosio A
    Behring Inst Mitt; 1984 Nov; (76):155-64. PubMed ID: 6395850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)].
    Thraenhart O; Kuwert EK
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):429-41. PubMed ID: 44937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
    Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA
    Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HDCS vaccine: a new highly potent rabies tissue culture vaccine without side-effects and its post-exposure use (author's transl)].
    Kuwert EK
    Immun Infekt; 1977 Oct; 5(5):193-207. PubMed ID: 914315
    [No Abstract]   [Full Text] [Related]  

  • 16. The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment.
    Wasi C; Chaiprasithikul P; Auewarakul P; Puthavathana P; Thongcharoen P; Trishnananda M
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):461-6. PubMed ID: 8160053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabies post-exposure treatment and side-effects in man using HDC (MRC 5) vaccine.
    Klietmann W; Domres B; Cox JH
    Dev Biol Stand; 1978; 40():109-13. PubMed ID: 567152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience.
    Toovey S
    Travel Med Infect Dis; 2007 Nov; 5(6):327-48. PubMed ID: 17983973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.